Stock Mumak

Stock Profile

Eli Lilly

Eli Lilly is one of the leading pharmaceutical companies worldwide. Growth drivers include Mounjaro, Zepbound, and a strong pipeline in obesity, diabetes, oncology, and neuroscience.

Stock Snapshot

Eli Lilly_Logo
Table HeaderTable Header
CompanyEli Lilly and Company
SectorHealthcare
ThemePharmaceuticals & Biotechnology
Business ModelDevelopment and commercialization of innovative medicines focusing on diabetes, obesity, and oncology
ISINUS5324571083
Market Capitalizationapprox. USD 1 trillion
UMBRELLA StatusActive
  • Geopolitics
  • Industry
  • Fundamentals
  • Sentiment
  • Technical Analysis

Price Performance (12 Months)

Aktuelle Unternehmensmeldungen

Eli Lilly
Healthcare

Valuation Analysis: Eli Lilly and Company

ISIN: US5324571083

Eli Lilly delivered strong revenue and earnings growth in the second quarter of 2026. Mounjaro and Zepbound are driving the business, revenue guidance is rising, and market sentiment is improving. At the same time, the high valuation, falling net prices in the US, heavy investment, and weak free cash flow remain key risks.
Compass 4 out of 5
Active icon
More research

Latest Portfolio Updates

Company Update

MUMAK SpotLight of the week: Eli Lilly and Palantir in focus

Eli Lilly strengthens its pipeline, Palantir remains volatile, and Johnson & Johnson gains momentum. The most important developments of the
Next Update
Company Update

PayPal Update: Is the stock stabilizing after the sell-off?

PayPal is recovering after the sell-off. The chart, analyst consensus, and fundamental development show initial signs of stabilization.
Next Update
Company Update

Palantir Update: What’s behind the volatility?

Following the strong August rally, Palantir is seeing pronounced price swings. Strong growth meets a high valuation and elevated market
Next Update
Company Update

SpaceX Update: Can the stock overcome the next resistance level?

SpaceX continues to gain momentum, as AI sentiment, positive analyst commentary, and Starship developments now encounter a key resistance zone.
Next Update